Sangano reWorld Health Organisation (WHO) razivisa nhasi kuti GlaxoSmithKline (GSK) ichavandudza chisungo chayo chekupa mushonga unouraya makonye wealbendazole kudzamara yabviswa pasi rose lymphatic filariasis sedambudziko rehutano hweveruzhinji. Pamusoro pezvo, panosvika 2025, mapiritsi emamiriyoni mazana maviri pagore ekurapa kweSTH achapihwa, uye panosvika 2025, mahwendefa emamiriyoni mashanu pagore ekurapa cystic echinococcosis.
Ichi chiziviso chazvino uno chinobva pakuzvipira kwekambani kwemakore makumi maviri nematatu kurwisa Zvirwere zvitatu zvinoregeredzwa zveTropical Diseases (NTDs) izvo zviri kutambudza dzimwe nharaunda dzine hurombo pasi rose.
Zvisungo izvi zvinongova chikamu chekuzvipira kunoshamisa kwakaitwa neGSK nhasi paMalaria uye Neglected Tropical Diseases Summit muKigali, apo vakazivisa mari inosvika bhiriyoni imwe yemadhora mumakore gumi kuti vakurumidze kufambira mberi pazvirwere zvinotapukira. - nyika dzemari. Press release).
Tsvagiridzo iyi ichatarisa pamishonga mitsva yekubudirira uye yekudzivirira nekurapa marariya, chirwere cherurindi, HIV (kuburikidza neViiV Healthcare) uye nezvirwere zvinogara pasi zvinopisa, uye kugadzirisa kurwisa hutachiona, izvo zvinoramba zvichikanganisa vanhu vazhinji uye zvichikonzera kufa kwakawanda. . Mutoro wechirwere munyika dzakawanda dzine mari shoma unopfuura 60%.